Neumora Therapeutics (NMRA) Stock Chart & Stock Price History → The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad) Free NMRA Stock Alerts $9.77 +0.35 (+3.72%) (As of 05/9/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Neumora Therapeutics Stock Price Performance5 Day Performance+5.62%1 Month Performance-32.81%3 Month Performance-46.96%6 Month Performance-7.83%Year-To-Date Performance-42.70% Receive NMRA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Neumora Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceProof that the Musk/Bezos rivalry is about to hit a new levelElon Musk Humiliated Since Jeff Bezos and Elon Musk first met in 2004 — they've been involved in a bitter feud… from rockets, to electric vehicles to who's the world richest person…for going on two decades these two have been at each others throats…Go here now for full story. NMRA Stock Chart for Thursday, May, 9, 2024 NMRA Chart by TradingView Neumora Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$9.81$9.42-3.98%$9.82$9.13428,339 shs$1.50 billion05/07/2024$9.35$9.81+4.92%$9.91$9.00483,967 shs$1.56 billion05/06/2024$9.25$9.35+1.08%$9.42$9.00441,583 shs$1.49 billion05/03/2024$9.22$9.25+0.33%$9.66$9.21378,314 shs$1.47 billion05/02/2024$9.10$9.22+1.32%$9.27$8.841.07 million shs$1.47 billion05/01/2024$9.09$9.10+0.11%$9.49$8.90499,254 shs$1.45 billion Get the Latest News and Ratings for NMRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neumora Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$9.46$9.09-3.91%$9.62$9.04283,533 shs$1.45 billion04/29/2024$9.15$9.46+3.39%$9.74$9.19410,798 shs$1.51 billion04/26/2024$9.06$9.15+0.99%$9.31$8.82677,265 shs$1.45 billion04/25/2024$9.59$9.06-5.53%$9.81$8.98803,509 shs$1.44 billion04/24/2024$10.30$9.59-6.89%$10.47$9.48598,684 shs$1.52 billion04/23/2024$10.41$10.30-1.06%$10.74$10.29328,667 shs$1.64 billion04/22/2024$10.18$10.41+2.26%$10.70$9.98487,040 shs$1.65 billion04/19/2024$10.55$10.18-3.51%$10.72$9.96784,213 shs$1.62 billion04/18/2024$10.47$10.55+0.76%$10.91$10.22404,261 shs$1.68 billion04/17/2024$10.96$10.47-4.47%$11.27$10.24606,855 shs$1.74 billion04/16/2024$11.19$10.96-2.06%$11.65$10.90745,132 shs$1.74 billion04/15/2024$13.56$11.19-17.48%$12.35$10.731.99 million shs$1.78 billion04/12/2024$14.01$13.56-3.21%$13.97$13.44231,162 shs$2.15 billion04/11/2024$14.67$14.01-4.50%$14.75$13.58462,480 shs$2.23 billion04/10/2024$14.54$14.67+0.89%$14.71$14.01469,393 shs$2.33 billion04/09/2024$14.70$14.54-1.09%$14.95$14.26482,309 shs$2.31 billion04/08/2024$14.33$14.70+2.58%$14.87$13.94569,194 shs$2.34 billion04/05/2024$13.73$14.33+4.37%$14.66$13.59726,639 shs$2.28 billion04/04/2024$13.30$13.73+3.23%$14.17$13.22379,925 shs$2.18 billion04/03/2024$13.77$13.30-3.41%$14.21$12.97550,748 shs$2.11 billion04/02/2024$13.94$13.77-1.22%$14.03$13.12660,483 shs$2.19 billion04/01/2024$13.75$13.94+1.38%$14.67$13.60923,356 shs$2.21 billion03/29/2024$13.75$13.75$13.83$12.60960,306 shs$2.18 billion03/28/2024$12.61$13.75+9.04%$13.83$12.60960,306 shs$2.18 billion03/27/2024$12.61$12.61$13.21$12.48923,880 shs$2.00 billion03/26/2024$12.44$12.61+1.37%$13.10$12.36455,369 shs$2.00 billion03/25/2024$13.21$12.44-5.83%$13.32$12.251.55 million shs$1.98 billion03/22/2024$13.98$13.21-5.51%$14.05$13.001.05 million shs$2.10 billion03/21/2024$13.99$13.98-0.07%$14.22$13.56790,273 shs$2.22 billion03/20/2024$14.03$13.99-0.29%$14.41$13.86656,545 shs$2.22 billion03/19/2024$14.16$14.03-0.92%$14.77$13.781.39 million shs$2.23 billion03/18/2024$15.09$14.16-6.16%$15.04$14.021.01 million shs$2.25 billion03/15/2024$15.13$15.09-0.26%$15.87$14.94647,792 shs$2.40 billion03/14/2024$14.81$15.13+2.16%$15.35$14.36887,568 shs$2.40 billion1970’s computer coder Issues Shocking AI Warning (Ad)Louis Navellier has spent four decades building a billion-dollar empire on the back of big data and technology… Now he's stepping forward with a shocking warning about how AI will soon impact the wealth of everyday Americans.Click here to watch his new video ASAP03/13/2024$17.35$14.81-14.64%$16.12$13.413.84 million shs$2.35 billion03/12/2024$18.05$17.35-3.88%$18.61$17.33820,529 shs$2.76 billion03/11/2024$18.00$18.05+0.28%$18.46$17.56262,531 shs$2.87 billion03/08/2024$19.00$18.00-5.26%$21.00$17.83409,427 shs$2.75 billion03/07/2024$18.40$19.00+3.26%$19.46$18.38116,974 shs$2.90 billion03/06/2024$17.32$18.40+6.24%$18.49$17.29267,746 shs$2.81 billion03/05/2024$17.38$17.32-0.35%$17.67$16.66182,070 shs$2.64 billion03/04/2024$18.05$17.38-3.71%$18.94$17.26160,379 shs$2.65 billion03/01/2024$17.63$18.05+2.38%$18.22$17.25422,372 shs$2.76 billion02/29/2024$17.69$17.63-0.34%$18.67$17.14354,857 shs$2.69 billion02/28/2024$18.57$17.69-4.74%$18.90$17.25340,561 shs$2.70 billion02/27/2024$18.54$18.57+0.16%$19.18$18.09258,965 shs$2.84 billion02/26/2024$19.28$18.54-3.84%$19.49$18.09237,172 shs$2.83 billion02/23/2024$18.82$19.28+2.44%$19.67$18.62192,497 shs$2.94 billion02/22/2024$17.99$18.82+4.61%$19.36$17.63223,009 shs$2.87 billion02/21/2024$18.44$17.99-2.44%$18.66$17.75265,402 shs$2.75 billion02/20/2024$19.76$18.44-6.68%$19.77$18.03310,496 shs$2.82 billion02/19/2024$19.76$19.76$19.82$18.47197,000 shs$3.02 billion02/16/2024$18.81$19.76+5.05%$19.82$18.47196,413 shs$3.02 billion02/15/2024$18.07$18.81+4.10%$19.13$16.77305,708 shs$2.87 billion02/14/2024$17.72$18.07+1.98%$19.90$17.60486,805 shs$2.76 billion02/13/2024$18.06$17.72-1.88%$18.11$17.46224,601 shs$2.71 billion02/12/2024$18.42$18.06-1.95%$18.45$17.77226,031 shs$2.76 billion02/09/2024$17.45$18.42+5.56%$18.49$17.27208,653 shs$2.81 billion02/08/2024$16.97$17.45+2.83%$17.52$16.97171,552 shs$2.66 billion Related Companies: ADMA Biologics Stock Chart 4D Molecular Therapeutics Stock Chart Tarsus Pharmaceuticals Stock Chart Vir Biotechnology Stock Chart Scholar Rock Stock Chart Cullinan Oncology Stock Chart Inhibrx Stock Chart Fusion Pharmaceuticals Stock Chart Autolus Therapeutics Stock Chart Twist Bioscience Stock Chart Receive NMRA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neumora Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NMRA) was last updated on 5/9/2024 by MarketBeat.com Staff From Our Partners1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeUrgent Nvidia WarningAltimetryThe Crypto 9-5 Escape PlanCrypto 101 Media348 million Americans lives to END as we know it?The Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neumora Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.